Origins and Scope of OTAs Study

The industry s collective response to charges that drug prices are too high or are increasing too fast has been to point to the high and increasing cost of pharmaceutical R D and their need to repay investors for their substantial and risky investments (325,326,505). Industry representatives have pointed to academic studies of the 

Pharmaceutical research and development is both a scientific and an economic process. Personnel, equipment and facilities come together in sophisticated organizations required for R D. 

Federal Government is anything but a passive observer of the industrial pharmaceutical R D process. The Federal Government subsidizes private R D, regulates the introduction and 

---